You are currently logged into
COVID Health Directory - My Account or Log Out
COVID Health COVID Health
  • Home
  • Basics
    • COVID-19 101
    • Prevention
    • Transmission
    • Symptoms
    • Testing
    • Vaccines
    • Treatment
  • News
    • Newsfeed
    • Science News
    • Features
    • Opinions
    • Email Newsletter
    • RSS Links
  • Hot Topics
    • Prevention
    • Symptoms
    • Vaccines
    • Treatment
    • Long Haulers
    • Health Equity
    • Face Masks
  • Health Tips
    • 7 Ways to Prevent the Spread of COVID-19
    • 7 maneras de prevenir la transmisión COVID-19
  • Community
    • Ask COVID Health
    • COVID Health Stories
    • Calendar
    • Polls
    • Surveys
  • About Us
    • About Us
    • Masthead
    • Advertise
    • Contact Us
  • Facebook
  • Twitter

© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

© 2021 Smart + Strong.
All Rights Reserved.
Terms of use and
Your privacy.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.

Advertisement

Share


Twitter
Facebook
Pinterest
Tumblr
Email

#Gilead Sciences

Tweet
  • Share

Remdesivir production.

FDA Approves Remdesivir for Hospitalized COVID-19 Patients

The antiviral drug is the first treatment for the new coronavirus to be approved in United States.

Downloadable infographics about NHAAD

National HIV/AIDS and Aging Awareness Day 2020

Nine key findings from a survey of HIV-positive people 50 and older. Plus: A special report on aging with HIV during COVID-19.

Remdesivir, an experimental drug being studied as a treatment for COVID-19

Remdesivir Shows Promise for COVID-19, but Not a Game Changer

FDA grants emergency use authorization, but randomized clinical trials of the antiviral drug show mixed results.

“We Are Seeing Few Cases of HIV-Positive People With Severe COVID-19”

As a result, researchers in Spain are testing whether HIV med Truvada, often used as PrEP, can also prevent COVID-19.

Supply of Our HIV and Hepatitis Meds Is Secure, Says Gilead

The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.

HIV Drugmaker Tests a Possible Treatment for New Coronavirus

Gilead Sciences is giving its antiviral remdesivir to nearly 1,000 people as part of two clinical trials.

Advertisement

Stay Logged In?

You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.

You Have Been Logged Out

Click here to log back in.